Other languages Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Delayed Nasdaq Other stock markets 11:18:01 2024-04-26 am EDT			5-day change	1st Jan Change
3.62 ^USD	+6.78%		-5.97%	+34.07%

Apr. 11	Sector Update: Health Care Stocks Softer Late Afternoon	MT
Apr. 11	Top Midday Gainers	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 11
Top Midday Gainers	Apr. 11
Sector Update: Health Care Stocks Decline Thursday Afternoon	Apr. 11
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge	Apr. 11
Top Premarket Gainers	Apr. 11
Eliem Therapeutics, Inc. and Tenet Medicines, Inc. Announces Management and Organization Changes	Apr. 11
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Harpoon Therapeutics Appoints Chief Legal Officer, Chief People Officer	Dec. 26
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Eliem Therapeutics Drops Kv7 Program, Explores Strategic Alternatives	23-07-20
Eliem Therapeutics Plans to Explore Strategic Alternatives	23-07-20
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Eliem Therapeutics, Inc. Announces Executive Changes	23-03-16
Eliem Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-06
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06
Bob Azelby to Depart as Chief Executive Officer of Eliem Therapeutics, Inc	23-02-09
Eliem Therapeutics, Inc. Announces Executive Changes	23-02-09
Eliem Therapeutics, Inc. Announces the Resignation of Leone Patterson from the Board of Directors	23-01-24
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Other languages

Filters